Plain-English translation of NCT05885698 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Carcinoma, Non-Small-Cell Lung research guide →This is an observational study—meaning researchers will follow your medical journey rather than test a new drug. The study tracks newly diagnosed non-small cell lung cancer patients across community cancer centers to see how genetic testing of your tumor helps doctors choose the best treatment for you. Researchers want to understand whether getting this type of testing improves outcomes and makes care more effective outside of large academic hospitals.
Most lung cancer research happens at major medical centers, but over 85% of cancer patients are actually treated at smaller, local community clinics. This study exists to show that community cancer centers can provide equally good care—including access to genetic tumor testing that identifies the best targeted treatments—while being more convenient and affordable for patients.
You likely qualify if…
You likely don't qualify if…
You would allow researchers to access and review your medical records over time as you receive treatment at your community cancer center. This is not a treatment study—you receive care as normal from your oncologist. Researchers simply track what genetic testing you receive, what treatments you're prescribed, and how you respond, collecting this real-world information to show whether genetic testing helps guide better treatment decisions in community settings.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
United States